Why it was recalled
Superpotent Drug
Product description
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Lot numbers, UPCs & expiration codes
Lot # 504950, Exp Date: 09/30/2026.
Where it was sold
US Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0866-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Aug 21, 2026
- FDA report date
- Sep 23, 2026
- Quantity
- 1955 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- VITRUVIAS THERAPEUTICS INC
Original FDA data
Every field from FDA enforcement report D-0866-2026, exactly as published.
Show all FDA fields
- City
- Auburn
- State
- AL
- Status
- Ongoing
- Country
- United States
- Event ID
- 99709
- Address
- 778 N Dean Rd Ste 600
- Code information
- Lot # 504950, Exp Date: 09/30/2026.
- Postal code
- 36830-4318
- Report date
- Sep 23, 2026
- Product type
- Drugs
- Recall number
- D-0866-2026
- Classification
- Class I
- Recalling firm
- VITRUVIAS THERAPEUTICS INC
- Product quantity
- 1955 bottles
- Reason for recall
- Superpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Distribution pattern
- US Nationwide.
- Recall initiation date
- Aug 21, 2026
- Initial firm notification
- Letter
- Center classification date
- Sep 22, 2026